96698 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Dipeptides with the first amino acid being heterocyclic
Sub-classes:INTERMEDIATE USED FOR FAPI SYNTHESIS, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#2CHIMERIC COMPOUND FOR DEGRADING CYCLOPHILIN A, PREPARATION METHOD THEREFOR, AND USE THEREOF
#3PEPTIDOMIMETIC INHIBITORS OF PROTEIN N-TERMINAL METHYLTRANSFERASE 1, COMPOSITION, AND METHOD OF USE
#4CONJUGATES AND METHODS OF USING THE SAME
#5INHIBITORS OF CYSTEINE PROTEASES
#6BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#7Compositions and methods for assessing eye vasculature
#8Cyclen based compounds, coordination compounds, peptides, pharmaceutical preparation, and use thereof
#9METHOD FOR MODIFYING AMINO GROUP IN MOLECULE WITH THE ZOLINIUM AND USE THEREOF
#10FUNCTIONALIZED PEPTIDES AS ANTIVIRAL AGENTS
#11COMPOSITIONS AND METHODS FOR ASSESSING EYE VASCULATURE
#12BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#13PROCESS FOR THE LIQUID PHASE SYNTHESIS OF H-INP-(D)BAL-(D)TRP-PHE-APC-NH2, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
#14BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#15Tubulysin analogues as anticancer agents and payloads for antibody-drug conjugates and methods of treatment therewith
#16Conjugates and methods of using the same
#17Chiral specific boron-containing compounds and their use in treating cancer or amyloidosis
#18NMDA ANTAGONIST PRODRUGS
#19BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#20UNIVERSAL ABT COMPOUNDS AND USES THEREOF
#21Boronate ester compounds and pharmaceutical compositions thereof
#22COMPOSITIONS AND METHODS FOR TREATING BETA-AMYLOID RELATED DISEASES
#23Tripeptide epoxy ketone protease inhibitors
#24BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#25PROCESS FOR THE LIQUID PHASE SYNTHESIS OF H-INP-(D)BAL-(D)TRP-PHE-APC-NH2, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
#26Compositions and methods for assessing eye vasculature
#27Compositions and methods for assessing eye vasculature
#28Small molecule DCN1 inhibitors and therapeutic methods using the same
#29MODIFIED AMINO ACIDS COMPRISING TETRAZINE FUNCTIONAL GROUPS, METHODS OF PREPARATION, AND METHODS OF THEIR USE
#30Boronate ester compounds and pharmaceutical compositions thereof
#31MALT1 inhibitors and uses thereof
#32BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#33Cytotoxic tubulysin compounds for conjugation
#34CHIRAL SPECIFIC BORON-CONTAINING COMPOUNDS AND THEIR USE IN TREATING CANCER OR AMYLOIDOSIS
#35COMPOSITIONS AND METHODS FOR ASSESSING EYE VASCULATURE
#36Boronate ester compounds and pharmaceutical compositions thereof
#37NMDA antagonist prodrugs
#38METHODS OF TREATING DEPRESSION AND OTHER RELATED DISEASES
#39BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#40COMPOSITIONS AND METHODS FOR TREATING BETA-AMYLOID RELATED DISEASES
#41Trifluoromethylpropanamide derivatives as HTRA1 inhibitors
#42NOVEL PYRIDINE DERIVATIVES
#43Bortezomib conjugates and methods using same
#44NOVEL LIGANDS FOR PREVENTION OF NEUROTOXICITY OF THE ALZHEIMER'S DISEASE RELATED AMYLOID-BETA PEPTIDE
#45MALT1 inhibitors and uses thereof
#46STAT6 inhibitors
#47BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#48Desacetoxytubulysin H and analogs thereof
#49Compositions and methods for assessing eye vasculature
#50Methods of treating depression and other related diseases
#51Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
#52Selective FKBP51 ligands for treatment of psychiatric disorders
#53NMDA antagonist prodrugs
#54BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#55Tripeptide compound, preparation method therefor, and application thereof
#56TUBULYSIN COMPOUNDS, METHODS OF MAKING AND USE
#57Compounds for enzyme inhibition
#58Heterologous Hosts
#59Disulfur bridge linkers for conjugation of a cell-binding molecule
#60Disulfur bridge linkers for conjugation of a cell-binding molecule
#61Macrocyclic inhibitors of flaviviridae viruses
#62Disulfur bridge linkers for conjugation of a cell-binding molecule
#63Dipeptides as inhibitors of human immunoproteasomes
#64Selective caspase inhibitors and uses thereof
#65Ether compounds for treatment of medical disorders
#66Pyrrole compounds as Granzyme B inhibitors
#67AMINOTHIAZOLES AND THEIR USES
#68NOVEL PYRIDINE DERIVATIVES
#69Tripeptide epoxy ketone protease inhibitors
#70Chiral specific boron-containing compounds and their use in treating cancer or amyloidosis
#71Ligands for prevention of neurotoxicity of the alzheimer's disease related amyloid-beta peptide
#72Cytotoxic tubulysin compounds for conjugation
#73NMDA antagonist prodrugs
#74Tubulysin compounds, methods of making and use
#75Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
#76Macrocyclic inhibitors of hepatitis C virus
#77STAT6 inhibitors
#78Tubulysin analogs and methods of making and use
#79METHODS OF MAKING CARFILZOMIB AND INTERMEDIATES THEREOF
#80Tubulysins and processes for preparing
#814-amino-4-oxobutanoyl peptides as inhibitors of viral replication
#82Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
#83Cysteine derivative
#84Compositions and methods for treating beta-amyloid related diseases
#85GLP-1 receptor modulators
#86Dipeptide and tripeptide epoxy ketone protease inhibitors
#87Methods of treating depression and other related diseases
#88Macrocyclic inhibitors of flaviviridae viruses
#89Process for producing Sovaprevir
#90Disulfur bridge linkers for conjugation of a cell-binding molecule
#91BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#92Tubulysin derivatives
#93Macrocyclic inhibitors of flaviviridae viruses
#94Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
#95RECEPTOR LIGAND LINKED CYTOTOXIC MOLECULES
#96SPIRO RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS
#97Macrocyclic inhibitors of hepatitis C virus
#98Macrocyclic and peptidomimetic compounds as broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, caliciviruses and coronaviruses
#99Tubulysin compounds, methods of making and use
#100THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
#101THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
#102Structural mimetics of proline-rich peptides and use thereof
#103Cyclin based inhibitors of CDK2 and CDK4
#104Selective caspase inhibitors and uses thereof
#105Boronate ester compounds and pharmaceutical compositions thereof
#106Boronate ester compounds and pharmaceutical compositions thereof
#107Complex-forming compounds
#1084-amino-4-oxobutanoyl peptides as inhibitors of viral replication
#109Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
#110Aminothiazoles and their uses
#111Macrocyclic inhibitors of hepatitis C virus
#112Tubulysin compounds, methods of making and use
#113Tubulysin compounds, methods of making and use
#114Integrin targeted synthetic ligands for diagnostic and therapeutic applications
#115Trypsin-like serine protease inhibitors, and their preparation and use
#116Compounds for enzyme inhibition
#117Bisphosphonate-prodrugs
#118Compounds for enzyme inhibition
#119Compounds for enzyme inhibition
#120Substituted adipic acid amides and uses thereof
#121Peptide deformylase inhibitors
#122Macrocyclic inhibitors of flaviviridae viruses
#123Methods of treating depression and other related diseases
#124Methods of treating depression and other related diseases
#125Selective inhibitors of prolylcarboxypeptidase
#126Methods of treating depression and other related diseases
#127Lipid dipeptide and gel
#128AMINIOTHIAZOLES AND THEIR USES
#129Inhibitors of HCV NS5A
#130Cysteine protease inhibitors
#131Methods of treating depression and other related diseases
#132Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use
#133Cysteine protease inhibitors
#134Methods of treating depression and other related diseases
#135Cysteine protease inhibitors
#136Collagen peptide, dipeptide and malady inhibitor
#137Tubulin inhibitors
#138Tubulin inhibitors
#139Specific inhibitors and active site probes for legumain
#140Macrocylic inhibitors of hepatitis C virus
#141INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME
#142Tubulysine derivatives
#143Anti-Viral Compounds
#144PNA DIAGNOSTIC USE
#145Method of treating tumors
#146Boronic ester and acid compounds, synthesis and uses
#147Trypsin-like serine protease inhibitors, and their preparation and use
#148Macrocyclic inhibitors of hepatitis C virus
#149Bradykinin B1-antagonists
#150Tubulysin compounds with high cytotoxicity, pharmaceutical compositions thereof, and method of use thereof
#151Labeling dye for detecting biomolecule, labeling kit, and method for detecting biomolecule
#152Lipid dipeptide and gel
#153THIOPEPTIDE PRECURSOR PROTEIN, GENE ENCODING IT AND USES THEREOF
#154Inhibitors of interleukin-1β converting enzyme
#155INHIBITORS OF SERINE PROTEASES
#156Collagen peptide, dipeptide and malady inhibitor
#157COMPOSITIONS AND METHODS FOR TREATING BETA-AMYLOID RELATED DISEASES
#158Selective caspase inhibitors and uses thereof
#159Mass- and property-tuned variable mass labeling reagents and analytical methods for simultaneous peptide sequencing and multiplexed protein quantification using thereof
#160Macrocyclic peptides as inhibitors of viral replication
#161Substituted pyrrolo[1,2-d][1,4]-diazonines and treatment of brain damage
#162PEPTIDE TURN MIMETICS
#1635-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection
#164Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
#165AMINOTHIAZOLES AND THEIR USES
#166Anti-viral compounds
#167Antimicrobial compounds and formulations
#168In vivo screen using chemical inducers of dimerization
#169Tubulysins and processes for preparing
#170NOVEL SULFONAMIDE INHIBITORS OF ASPARTYL PROTEASE
#171Cysteine-protease inhibitors
#172Reactive mass labels
#173Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
#174Prober cleaning block assembly
#175Substituted imidazo[1,2-A]pyrazine derivatives as alpha-helix mimetics and method relating to the treatment of cancer stem cells
#176SYNTHESIS OF DESACETOXYTUBULYSIN H AND ANALOGS THEREOF
#177CYCLIC MALONAMIDES AS INHIBITORS OF A BETA PROTEIN PRODUCTION
#178CYCLIC MALONAMIDES AS INHIBITORS OF ABETA PROTEIN PRODUCTION
#179BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#180EPONEMYCIN AND EPOXOMICIN ANALOGS AND USES THEREOF
#181Macrocyclic inhibitors of hepatitis C virus
#182CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION
#183Boronic ester and acid compounds, synthesis and uses
#184Compounds for enzyme inhibition
#185Self-assembled Fmoc-ff hydrogels
#186Hepatitis C inhibitor dipeptide analogs
#187Aminothiazoles and their uses
#1882-(aminomethyl)-5-chlorobenzylamide derivatives and their use as inhibitors of the clotting factor Xa
#189Cycloalkylcarbonylamino acid derivative and process for producing the same
#190PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES
#191Anti-cancer compounds
#192VLA-4 Antagonists
#193Macrocyclic inhibitors of hepatitis C virus
#1944-amino-4-oxobutanoyl peptides as inhibitors of viral replication
#195α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
#196POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF
#197Integrin targeted synthetic ligands for diagnostic and therapeutic applications
#198Novel sulfonamide inhibitors of aspartyl protease
#199Synthesis of carbohydrate-templated amino acids and methods of using same
#200Cyclic malonamides as inhibitors of aβ protein production
#201EFTU inhibitors or aminothiazoles and their uses
#202HCV PROTEASE INHIBITORS
#203Amino acid derivatives and pharmaceutical uses thereof
#204Substituted tetrahydroisoquinolines as β-secretase inhibitors
#205Selective inhibitors of neurotensin degrading enzymes
#206Peptidomimetic Compounds and Preparation of Biologically Active Derivatives
#207Boronic ester and acid compounds, synthesis and uses
#208BIS-AMINO ACID HYDROXYETHYLAMINO SULFONAMIDE RETROVIRAL PROTEASE INHIBITORS
#209Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
#210Myd88 Homodimerization Inhibitors
#211Inhibitors of interleukin-1β converting enzyme
#212Cyclic malonamides as inhibitors of Aβ protein production
#213Boronic ester and acid compounds, synthesis and uses
#214Gamma-lactams as beta-secretase inhibitors
#215Substituted piperazines and methods of use
#216Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
#217VLA-4 antagonists
#218Methods for the synthesis of arginine-containing peptides
#219Protease inhibitors
#220Alpha-helix mimetics and method relating to the treatment of cancer stem cells
#221N- or C- terminally modified small peptides
#222Compounds for enzyme inhibition
#223Inhibitors of serine proteases
#224Hepatitis C virus inhibitors
#225Process for purifying interferon beta
#226α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
#227N and/or N derivatized, metal and organic protected L-histidine for coupling to biomolecules for highly efficient labeling with [M(OH)(CO)] by coordination
#228Pyrazole compounds as HSP90 inhibitors for the treatment of cancer
#229Base-substituted benzylamine analogs for use as coagulation factor Xa inhibitors, the production and use thereof
#230Hybrid molecules QA where Q is an aminoquinoline and A is an antibiotic residue, the synthesis and uses thereof as antibacterial agents
#231Dipeptide phenyl ethers
#232Peptido-mimetic compounds containing rgd sequence useful as integrin inhibitors, and intermediates thereof
#233Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
#234Process for the manufacture of an enantiopure compound
#235Aza-peptide macrocyclic hepatitis c serine protease inhibitors
#236Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
#237Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
#238Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
#239Beta-sheet mimetics and methods relating to the use thereof
#240Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
#241α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
#242β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
#243Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient
#244Neuroprotective macrocyclic compounds and methods for their use
#245Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
#246Peptide gap junction modulators
#247Sulfonamide inhibitors of aspartyl protease
#248Anti-cancer compounds
#249Hepatitis C virus inhibitors
#2502-hydroxytetrahydrofuran derivatives and use thereof as medicaments
#251Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
#252Pyrrolidin-2-one derivatives as inhibitors of factor xa
#253Pyrrolidin-2-one derivatives as inhibitors of factor xa
#254Peptide nucleic acids
#255Method for synthesising perindopril and the pharmaceutically acceptable salt thereof
#256Cyclic malonamides as inhibitors of Aβ protein protection
#257Flexible method and apparatus for high throughput production and purification of multiple proteins
#258Boronic ester and acid compounds, synthesis and uses
#259Cyanomethyl derivatives as cysteine protease inhibitors
#260α- and β-amino acid hydroxyethlamino sulfonyl urea derivatives useful as retroviral protease inhibitors
#261Gamma-lactams as beta-secretase inhibitors
#262Hepatitis C inhibitor dipeptide analogs
#263Use of nucleic acid analogues in diagnostics and analytical procedures
#264Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
#265Novel amide derivatives as growth hormone secretagogues
#266Anti-inflammatory compositions and methods
#267α- and β-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
#268α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
#269Protease inhibitors
#270Novel compounds that inhibit tryptase activity
#271Non-aggregating non-quenching oligomers comprising nucleotide analogs; methods of synthesis and use thereof
#272Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
#273Derivatives of 2-hydroxytetrahydrofuran and their use as medicaments
#274Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
#275Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
#276Removal of ruthenium by-product by supercritical fluid processing
#277Vitronectin receptor antagonist pharmaceuticals
#278Inhibitors of interleukin-1beta converting enzyme
#279Compounds and methods for treatment of thrombosis
#280Novel guanidinyl derivatives
#281Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
#282Inhibitors of the blood-clotting factor xa, production thereof and use of the same
#283Eponemycin and epoxomicin analogs and uses thereof
#284Dipeptide phenyl ethers
#285Aza-peptide macrocyclic hepatitis C serine protease inhibitors
#286Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
#287Solid salts of benzazepine compounds and pharmaceutical compositions containing them
#288Cyclic malonamides as inhibitors of A-β protein production
#289Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient
#290Peptide nucleic acids and synthetic procedures therefor
#291ACE inhibitor derivatives